Mark Graham II MD has Hematology/oncology as his primary medical specialty. Their primary office is: 210 Ashville Ave in Cary, North Carolina.
There is an additional office location, for a total of two, for Mark Graham II MD that can be viewed further down.
They're a part of the: Wakemed Specialists Group Llc medical group which has around 687 members. You can call their office at 919-350-2800 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Mayo Medical School and graduated in 1982 (around 42 years of experience). They are listed as doing telehealth appointments.
Mark Graham II MD
Wakemed Specialists Group Llc
210 Ashville Ave
Cary, North Carolina 27518
919-350-2800
Phone: 919-350-2800
Enter a starting address:
Medical School: Mayo Medical School
Graduation Year: 1982
The Primary Medical Specialty for Mark Graham II MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 42
PAC (PECOS ID)#: 6305732348
NPI #: 1760481667
NPI Created On: 07/21/2005
NPI Last Updated Listed as: 11/09/2022
Primary Taxonomy Code: 207R00000X
License Number:
39812
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: SPA, English, Spanish.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $28
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788651639
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Drug or Biological: Biological
Product Category #2: Oncology
Name Of Drug #2:: IMBRUVICA
Associated Drug #2: 57962-140-09
Payments Total: $24
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783717279
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Hematology
Name of Drug #1: REBLOZYL
Open Associated Drug #1: 59572-711-01
Payments Total: $22
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783717283
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Hematology
Name of Drug #1: REBLOZYL
Open Associated Drug #1: 59572-711-01
Payments Total: $22
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783717303
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Hematology
Name of Drug #1: REBLOZYL
Open Associated Drug #1: 59572-711-01
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest: Yes
Third party is a Charity:: No
Record ID:: 835946501
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: BioOncology
Name of Drug #1: Perjeta
Open Associated Drug #1: 50242-145-01
Drug or Biological: Biological
Product Category #2: BioOncology
Name Of Drug #2:: Kadcyla
Associated Drug #2: 50242-087-01
Drug or Biological #3:: Biological
Product Category #3: BioOncology
Name of Drug: Phesgo
Name Of Drug #3: 50242-245-01
Payments Total: $18
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 812699099
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: MEKINIST
Open Associated Drug #1: 0078-0666-15
Drug or Biological: Drug
Product Category #2: ONCOLOGY
Name Of Drug #2:: TAFINLAR
Associated Drug #2: 0078-0681-66
Drug or Biological #3:: Drug
Product Category #3: ONCOLOGY
Name of Drug: TABRECTA
Name Of Drug #3: 0078-0709-56
Payments Total: $18
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 832339883
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: TAZVERIK
Open Associated Drug #1: 72607-100-00
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 834086367
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: NERLYNX
Open Associated Drug #1: 70437-240-18
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 834090569
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: NERLYNX
Open Associated Drug #1: 70437-240-18
Payments Total: $15
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 843486963
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: JEVTANA
Open Associated Drug #1: 0024-5824-11
1. Wakemed Specialists Group Llc
3000 New Bern Ave
Raleigh, NC 27610
Group Members: 687
Phone: 919-350-2800
Enter a starting address:
150 Pkwy Office Ct
Cary, NC
Rex Hospital Inc
150 Pkwy Office Ct
Cary, NC
Rex Hospital Inc
150 Pkwy Office Ct
Cary, NC
Rex Hospital Inc
210 Ashville Ave
Cary, NC
Wakemed Specialists Group Llc
150 Pkwy Office Ct
Cary, NC
Rex Hospital Inc
1900 Kildaire Farm Rd
Cary Nc 27518-6616
Wakemed Specialists Group Llc
Hospitalist
3000 New Bern Ave
Raleigh Nc 27610-1231
Wakemed Specialists Group Llc
Hospitalist
1900 Kildaire Farm Rd
Cary Nc 27518-6616
Wakemed Specialists Group Llc
Internal Medicine
3000 New Bern Ave
Raleigh Nc 27610-1231
Wakemed Specialists Group Llc
Internal Medicine
3024 New Bern Ave
Raleigh Nc 27610-1247
Wakemed Specialists Group Llc
General Surgery
10010 Falls Of Neuse Rd
Raleigh Nc 27614-8494
Wakemed Specialists Group Llc
General Surgery
View all 687 members of Wakemed Specialists Group Llc medical group